Centene Corp
NYSE:CNC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
57.46
80.41
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Centene Corp
Centene Corp
Operating Income
Centene Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Centene Corp
NYSE:CNC
|
Operating Income
$3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
24%
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Operating Income
$32.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
Molina Healthcare Inc
NYSE:MOH
|
Operating Income
$1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
33%
|
|
|
Humana Inc
NYSE:HUM
|
Operating Income
$3.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Healthequity Inc
NASDAQ:HQY
|
Operating Income
$179.2m
|
CAGR 3-Years
43%
|
CAGR 5-Years
15%
|
CAGR 10-Years
28%
|
|
|
Elevance Health Inc
NYSE:ELV
|
Operating Income
$9.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Centene Corp
Glance View
Centene Corporation is a prominent player in the healthcare sector, known for its innovative approach to delivering affordable and accessible health insurance solutions. Founded in 1984, this Fortune 500 company has grown significantly, primarily focusing on government-sponsored healthcare programs, including Medicaid and Medicare. Centene's diverse health plans serve a wide demographic, including low-income families, the aging population, and those with complex healthcare needs. Through strategic acquisitions, robust technology investments, and a commitment to community-based care, Centene has positioned itself as a key provider in the rapidly evolving healthcare landscape. What sets Centene apart is its relentless focus on integrated healthcare solutions and patient-centric services. By leveraging data analytics and personalized care strategies, the company aims to improve health outcomes while managing costs effectively. In recent years, Centene has expanded its footprint by acquiring organizations that enhance its capabilities and market presence. This growth strategy not only strengthens its service offerings but also fortifies its competitive edge. For investors, Centene represents a compelling opportunity, combining steady revenue growth, a commitment to innovation, and a mission-driven approach that aims to bridge the gap in healthcare access for underserved populations.
See Also
What is Centene Corp's Operating Income?
Operating Income
3B
USD
Based on the financial report for Sep 30, 2024, Centene Corp's Operating Income amounts to 3B USD.
What is Centene Corp's Operating Income growth rate?
Operating Income CAGR 10Y
24%
Over the last year, the Operating Income growth was -25%.
You don't have any saved screeners yet
